Study Reveals MASLD, MetALD Responsible for One-Third of ICU Cirrhosis Cases
By Lori Solomon HealthDay Reporter
TUESDAY, Aug. 6, 2024 -- Metabolic dysfunction-associated steatotic liver disease (MASLD)-related and metabolic and alcohol-related liver disease (MetALD)-related cirrhosis is responsible for one-third of cirrhosis cases seen in the intensive care unit (ICU), according to a study published online July 22 in Alimentary Pharmacology and Therapeutics.
Philippe Sultanik, M.D., Ph.D., from Sorbonne Université in Paris, and colleagues assessed the prevalence of MASLD-related cirrhosis in the ICU (January 2019 to September 2021) among 315 patients (39 with MASLD, 160 with alcohol-related liver disease [ALD], and 116 with MetALD cirrhosis).
The researchers found that patients in the MASLD group were significantly older (65 years versus 57 and 59 years, respectively) and had lower Child-Pugh (8 versus 11 and 10, respectively) and Model for End-Stage Liver Disease scores (17 versus 22 and 21, respectively). There were no differences in one-year transplant-free survival between the groups (53 percent versus 54 and 54 percent, respectively). All groups had cardiovascular mortality of less than 5 percent. The MASLD group had a significantly higher one-year probability of developing hepatic encephalopathy (73 percent versus 27 and 21 percent, respectively).
"MASLD or MetALD was responsible for one-third of the causes of cirrhosis in the ICU," the authors write. "MASLD-related cirrhosis is as severe as ALD-related cirrhosis. Liver transplantation should be rapidly discussed."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Metabolic Dysfunction-Linked Steatotic Liver Disease Tied to Increased Preterm Birth Risk
TUESDAY, May 20, 2025 -- Metabolic dysfunction-associated steatotic liver disease (MASLD) in pregnant women is a risk factor for preterm birth, according to a study published...
Calorie Restrictions, Low-Fat Diets May Reduce Depressive Symptoms
MONDAY, May 19, 2025 -- Among adults with elevated cardiometabolic risk, calorie restrictions and low-fat diets may reduce depressive symptoms, according to a review published...
Metabolic and Bariatric Surgery Increased in Adolescents From 2021 to 2023
WEDNESDAY, May 14, 2025 -- Despite the approval of second-generation antiobesity medications, metabolic and bariatric surgery (MBS) use among U.S. adolescents increased from 2021...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.